Found 5 matching trials
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
PHASE2A multicenter, open-label, prospective study to investigate immune boost re...
Location
Arizona Urology Specialists
Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer
PHASE2This randomized pilot clinical trial studies sipuleucel-T with or without d...
Location
University of Wisconsin Carbone Cancer Center
Sipuleucel-T as Neoadjuvant Treatment in Prostate Cancer
PHASE2This is an open label, Phase 2 trial of immunotherapy with sipuleucel-T as ...
Location
USC / Norris Comprehensive Cancer Center
Sipuleucel-T in Metastatic Castrate Resistant Prostate Cancer
PHASE2Multicenter open label, uncontrolled study that enrolled men with metastati...
Location
Orange County Urology Associates
PROvenge Treatment and Early Cancer Treatment
PHASE3The PROTECT-PROvenge Treatment and Early Cancer Treatment trial was a Phase...
Location
Alta Bates Comprehensive Cancer Center